pre-seed
Stage
About
Sapreme Technologies is a preclinical-stage biotech company developing RNA therapeutics using proprietary endosomal escape technology to enable targeted intracellular delivery of large molecules such as ASOs and siRNAs for genetically driven diseases, including Duchenne muscular dystrophy.
Explore Sapreme Technologies's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.